GSK Posts 340B Refund Notice on High-Revenue Asthma Treatment
Drugmaker GlaxoSmithKline has posted another refund notice to 340B providers related to purchases of its high-earning asthma drugs. A Jan. [...]
*Sign up for news summaries and alerts from 340B Report